Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
The Impact of Education on the Rehabilitation of Patients Hospitalized Due to Chronic Obstructive Pulmonary Disease.
The planned research will enable the assessment of rehabilitation's effects using two pulmonary rehabilitation models: conventional and supplemented with an education program for patients hospitalized due to chronic obstructive pulmonary disease.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years to 70 Years |
Eligibility | Inclusion Criteria: - Diagnosed chronic obstructive pulmonary disease in the exacerbation phase - Moderate stage (II) of the disease - Independence in basic activities of daily living (above 86 points on the Barthel scale) - Age 55 y.o. to 70 y.o. - No additional respiratory support (e.a. cardiopulmonary bypass machine, ventilator) - Informed, voluntary consent to participate in research. Exclusion Criteria: - Diagnosed chronic obstructive pulmonary disease in remission - Stages I, III and IV of the disease - a forms with mild, severe, and very severe obstruction - Hospitalization in the intensive care unit, current health condition precluding participation in the study - Age under 55 y.o. and over 70 y.o. - Cognitive deficits impairing the ability to understand and execute commands - Concomitant oncological, neurological, orthopedic, and psychiatric diseases may affect the examined persons' circulatory and respiratory functions, functional efficiency, quality of life, and emotional state. - Failure to complete a 14-day rehabilitation program - Lack of informed, voluntary consent to participate in research. |
Country | Name | City | State |
---|---|---|---|
Poland | University of Rzeszów | Rzeszów |
Lead Sponsor | Collaborator |
---|---|
University of Rzeszow |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dynamic lung capacities (spirometry) | Measurements will be performed with certified spirometer and the parameters analyzed will be Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 Second (FEV1) measured in litres [L]. | First examination- before the start of the interventions | |
Primary | Dynamic lung capacities (spirometry) | Measurements will be performed with certified spirometer and the parameters analyzed will be Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 Second (FEV1) measured in litres [L]. | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Modified Tiffeneau-Pinelli index (spirometry) | Measurement will be performed with certified spirometer and the parameter analyzed will be the ratio of Forced Expiratory Volume in 1 Second to Forced Vital Capacity (FEV1/FVC ratio) presented as a decimal fraction. | First examination- before the start of the interventions | |
Primary | Modified Tiffeneau-Pinelli index (spirometry) | Measurement will be performed with certified spirometer and the parameter analyzed will be the ratio of Forced Expiratory Volume in 1 Second to Forced Vital Capacity (FEV1/FVC ratio) presented as a decimal fraction. | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Oxygen saturation | Measurements will be performed with pulse oximeter and the parameter analyzed will be oxygen saturation by pulse oximetry (SpO2, percentage of oxygen in patients' blood). | First examination- before the start of the interventions | |
Primary | Oxygen saturation | Measurements will be performed with pulse oximeter and the parameter analyzed will be oxygen saturation by pulse oximetry (SpO2, percentage of oxygen in patients' blood). | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Pulse rate | Measurements will be performed with pulse oximeter and the parameter analyzed will be the number of patients' heart beats per minute. | First examination- before the start of the interventions | |
Primary | Pulse rate | Measurements will be performed with pulse oximeter and the parameter analyzed will be the number of patients' heart beats per minute. | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Acid-base balance | The gasometry results will be taken from patients' medical documentation. The parameters analyzed will be oxygen pressure (pO2) and carbon dioxide pressure (pCO2). | First examination- before the start of the interventions | |
Primary | Acid-base balance | The gasometry results will be taken from patients' medical documentation. The parameters analyzed will be oxygen pressure (pO2) and carbon dioxide pressure (pCO2). | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Exercise tolerance assessed by 6-minute walking test (6MWT) | The test will be performed in 20-meter long hospital corridor. The patient should walk the distance at his own rhythm and pace, using orthopedic aids (if necessary). The patient will be informed that they can stop the test at any time if they feel it is necessary. The distance traveled in meters in 6 minutes will be analyzed. | First examination- before the start of the interventions | |
Primary | Exercise tolerance assessed by 6-minute walking test (6MWT) | The test will be performed in 20-meter long hospital corridor. The patient should walk the distance at his own rhythm and pace, using orthopedic aids (if necessary). The patient will be informed that they can stop the test at any time if they feel it is necessary. The distance traveled in meters in 6 minutes will be analyzed. | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Physical performance assessment by Fullerton functional fitness test | The test comprising muscle endurance, aerobic capacity, flexibility, agility, and balance assessment. The test consist of 6 activities: 1. Arm Curl Test (number of forearm flexions in 30 seconds); 2. Back Scratch (the distance between middle fingers); 3. 30 Second Chair Stand (number of standings in 30 seconds); 4. Chair Sit-and-Reach ( '+' if fingers can reach toes in sitting position, '-' if fingers cannot reach toes in sitting position); 5. 8 - Foot Up-and-Go (8-foot walking time); 6. 2-Minute Step-in-Place (the number of lifts of the right leg). | First examination- before the start of the interventions | |
Primary | Physical performance assessment by Fullerton functional fitness test | The test comprising muscle endurance, aerobic capacity, flexibility, agility, and balance assessment. The test consist of 6 activities: 1. Arm Curl Test (number of forearm flexions in 30 seconds); 2. Back Scratch (the distance between middle fingers); 3. 30 Second Chair Stand (number of standings in 30 seconds); 4. Chair Sit-and-Reach ( '+' if fingers can reach toes in sitting position, '-' if fingers cannot reach toes in sitting position); 5. 8 - Foot Up-and-Go (8-foot walking time); 6. 2-Minute Step-in-Place (the number of lifts of the right leg). | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Fatigue assessment using modified Borg scale | Fatigue will be examined during physical activity and the level of fatigue will be marked on a scale from 1 (no fatigue) to 10 (very very hard fatigue). | First examination- before the start of the interventions | |
Primary | Fatigue assessment using modified Borg scale | Fatigue will be examined during physical activity and the level of fatigue will be marked on a scale from 1 (no fatigue) to 10 (very very hard fatigue). | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Fatigue assessment using modified Borg scale | Fatigue will be examined during physical activity and the level of fatigue will be marked on a scale from 1 (no fatigue) to 10 (very very hard fatigue). | Third examination - two months after discharge from the hospital (follow- up) | |
Primary | Dyspnea assessment with Medical Research Council dyspnea scale | Perceived breathlessness degree will be marked on a scale 0 (no breathlessness) to 4 (breathlessness at rest). | First examination- before the start of the interventions | |
Primary | Dyspnea assessment with Medical Research Council dyspnea scale | Perceived breathlessness degree will be marked on a scale 0 (no breathlessness) to 4 (breathlessness at rest). | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Dyspnea assessment with Medical Research Council dyspnea scale | Perceived breathlessness degree will be marked on a scale 0 (no breathlessness) to 4 (breathlessness at rest). | Third examination - two months after discharge from the hospital (follow- up) | |
Primary | Quality of life assessment using World Health Organization Quality-of-Life Scale (WHOQOL-BREF) | Assessment of quality of life, health and other areas. The scale contains 26 items, divided into four domains: physical health (7 items), psychological health (6 items), social relations (3 items), and environmental health (8 items), as well overall quality of life and general health (2 items). Patients express how much they have experienced the items in the preceding 2 weeks on a 5-point Likert scale ranging from 1 (not at all) to 5 (completely). The final score is transformed linearly to a 0-100-scale, where higher scores denote higher quality of life. | First examination- before the start of the interventions | |
Primary | Quality of life assessment using World Health Organization Quality-of-Life Scale (WHOQOL-BREF) | Assessment of quality of life, health and other areas. The scale contains 26 items, divided into four domains: physical health (7 items), psychological health (6 items), social relations (3 items), and environmental health (8 items), as well overall quality of life and general health (2 items). Patients express how much they have experienced the items in the preceding 2 weeks on a 5-point Likert scale ranging from 1 (not at all) to 5 (completely). The final score is transformed linearly to a 0-100-scale, where higher scores denote higher quality of life. | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Quality of life assessment using World Health Organization Quality-of-Life Scale (WHOQOL-BREF) | Assessment of quality of life, health and other areas. The scale contains 26 items, divided into four domains: physical health (7 items), psychological health (6 items), social relations (3 items), and environmental health (8 items), as well overall quality of life and general health (2 items). Patients express how much they have experienced the items in the preceding 2 weeks on a 5-point Likert scale ranging from 1 (not at all) to 5 (completely). The final score is transformed linearly to a 0-100-scale, where higher scores denote higher quality of life. | Third examination - two months after discharge from the hospital (follow- up) | |
Primary | Anxiety and depression assessment using HADS scale | The scale consists of 16 statements to which the respondent refers on a four-point scale. Eight statements are used to measure anxiety and depression, each of which is rated on a scale of 0 to 3 points. The cut-off threshold is 7 points for depression and 7 points for anxiety. The intensity of depressed mood and anxiety will be analyzed. | First examination- before the start of the interventions | |
Primary | Anxiety and depression assessment using HADS scale | The scale consists of 16 statements to which the respondent refers on a four-point scale. Eight statements are used to measure anxiety and depression, each of which is rated on a scale of 0 to 3 points. The cut-off threshold is 7 points for depression and 7 points for anxiety. The intensity of depressed mood and anxiety will be analyzed. | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Anxiety and depression assessment using HADS scale | The scale consists of 16 statements to which the respondent refers on a four-point scale. Eight statements are used to measure anxiety and depression, each of which is rated on a scale of 0 to 3 points. The cut-off threshold is 7 points for depression and 7 points for anxiety. The intensity of depressed mood and anxiety will be analyzed. | Third examination - two months after discharge from the hospital (follow- up) | |
Primary | Activities of daily living assesment using Lawton Instrumental Activities of Daily Living (IADL) Scale | Life independence test, i.e. ensuring the functioning of the household by a sick person based on his/her ability to cope in the external environment or with a complex activity such as using the telephone and ensuring the related opportunities. The ability of basic functioning in the environment will be analyzed and each of 8 items will be rate trichotomously (1 = unable, 2 = needs assistance, 3 = independent) and sum the eight responses. The final total score ranges from 8 (low functioning, dependent) to 24 (high function, independent). | First examination- before the start of the interventions | |
Primary | Activities of daily living assesment using Lawton Instrumental Activities of Daily Living (IADL) Scale | Life independence test, i.e. ensuring the functioning of the household by a sick person based on his/her ability to cope in the external environment or with a complex activity such as using the telephone and ensuring the related opportunities. The ability of basic functioning in the environment will be analyzed and each of 8 items will be rate trichotomously (1 = unable, 2 = needs assistance, 3 = independent) and sum the eight responses. The final total score ranges from 8 (low functioning, dependent) to 24 (high function, independent). | Second examination- at the end of the 14-day rehabilitation program | |
Primary | Activities of daily living assesment using Lawton Instrumental Activities of Daily Living (IADL) Scale | Life independence test, i.e. ensuring the functioning of the household by a sick person based on his/her ability to cope in the external environment or with a complex activity such as using the telephone and ensuring the related opportunities. The ability of basic functioning in the environment will be analyzed and each of 8 items will be rate trichotomously (1 = unable, 2 = needs assistance, 3 = independent) and sum the eight responses. The final total score ranges from 8 (low functioning, dependent) to 24 (high function, independent). | Third examination - two months after discharge from the hospital (follow- up) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|